Abstract A broad region on chromosome 12p13 has been intensely investigated for novel genetic variants associated with Alzheimer disease (AD). We examined this region with 23 microsatellite markers using 124 North European (NE) families and 209 Caribbean Hispanic families with late-onset AD (FAD). Significant evidence for linkage was present in a 5-cM interval near 20 cM in both the NE FAD (LOD=3.5) and the Caribbean Hispanic FAD (LOD=2.2) datasets. We further investigated these families and an independent NE case-control dataset using 14 single nucleotide polymorphisms (SNPs). The initial screening of the region at ∼20 cM in the NE case-control dataset revealed significant association between AD and seven SNPs in several genes, with the strongest result for rs2532500 in TAPBPL (p = 0.006). For rs3741916 in GAPDH, the C allele, rather than the G allele as was observed by Li et al. (Proc Natl Acad Sci U S A 101 (44): [15688][15689][15690][15691][15692][15693] 2004), was the risk allele. When the two family datasets were examined, none of the SNPs were significant in NE families, but two SNPs were associated with AD in Caribbean Hispanics: rs740850 in NCAPD2 (p=0.0097) and rs1060620 in GAPDH (p=0.042). In a separate analysis combining the Caribbean Hispanic families and NE cases and controls, rs740850 was significant after correcting for multiple testing (empirical p=0.0048). Subsequent haplotype analyses revealed that two haplotype sets-haplotype C-A at SNPs 6-7 within NCAPD2 in Caribbean Hispanics, and haplotypes containing C-A-T at SNPs 8-10 within GAPDH in Caribbean Hispanic family and NE case-control datasets-were associated with AD.
Introduction
Alzheimer disease (AD) occurs as a late-onset disorder with increasing frequency after the age of 65. Genome-wide linkage analyses have identified several loci as potential sites containing late-onset AD susceptibility genes [1] [2] [3] . One of the most consistent results has been on chromosome 12p. Linkage was originally reported at ∼45 cM (LOD= 3.5) [3] . Previously, we confirmed this locus using 53 North European families multiply affected by AD with the strongest evidence for linkage near the markers D12S358 (26 cM) and D12S96 (68 cM) [4] , and in 79 Caribbean Hispanic families where two-point linkage analysis using affected sib pairs yielded LOD scores of 3.15 at D12S1623 (16 cM) and 1.43 at D12S1042 (49 cM) [5] . Although several genes on chromosome 12 have been implicated as potential sites for AD-associated variants (http://www. alzgene.org), none have been confirmed.
It is not surprising that several independent studies have reported significant support for linkage in different but nearby regions of chromosome 12p, given the complex underlying biology of AD. It has been shown that the actual disease locus can reside as far as 20 cM away from the markers with the maximum LOD scores [6, 7] . For example, after fine mapping and genotyping additional family members [3] , Scott and colleagues [8] found that support for linkage expanded to include ∼40 cM over both arms of the chromosome between 26 cM (D12S358 LOD=2.5) and 67 cM (D12S390 LOD= 2.0). Thus, potentially the AD-linked locus includes the entire 67 cM interval on chromosome 12p.
In this study, we fine mapped the chromosome 12 locus using linkage analysis with 23 microsatellite markers (14-83 cM) in two expanded groups of families multiply affected by late-onset AD (FAD) consisting of 124 North European and 209 Caribbean Hispanic pedigrees. In the regions with the highest support for linkage, we analyzed 14 single nucleotide polymorphisms (SNPs) that were chosen based on a report of significant association between sporadic AD and variations in or nearby the glyceraldehyde-3-phosphate dehydrogenase gene (GAPDH) [9] .
Materials and methods

Participants
We used two FAD datasets: 124 North European families and 209 Caribbean Hispanic families. The North European FAD dataset included 685 family members, and the Caribbean Hispanic FAD dataset included 1,147 family members who were recruited in the Dominican Republic, Puerto Rico, and in New York City. The clinical characteristics of the North European FAD [4] and Caribbean Hispanic FAD [10] datasets have been previously described and have a mean age at onset of 70 (SD=9) and 73 (SD= 11) years, respectively. The third cohort consisted of 183 patients with AD (36% males) and 224 controls (41% males) of North European ancestry (Britain, France, Germany) drawn from the same populations as the North European FAD dataset [11] . The mean age-at-onset for cases was 76 years (SD=7), and the mean age at follow-up for unrelated controls was 73 years (SD=8). The characteristics of the three datasets are summarized in Table 1 .
The diagnosis of AD was based on direct examination, guided by the National Institute of Neurological Disorders and Stroke-Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) diagnosis criteria [12] . Informed consent was obtained from all individuals participating in the study.
Genotyping
Genomic DNA was isolated from blood samples using a QIAGEN kit. Prior to performing linkage analysis, we checked for Mendelian inconsistencies in marker data using the PEDCHECK program [13] . In the North European and Caribbean Hispanic FAD datasets, we genotyped 23 microsatellite markers mapped on chromosome 12 at an average inter-marker distance of ∼3.1 cM (14-83 cM) according to the Marshfield Map set 13 (http://research.marshfieldclinic. org/genetics; Table 2 ). The PCR conditions for genotyping of the microsatellite makers were obtained from the Genome Database (www.gdb.org). For the SNP-based study, we focused on the 167-kb interval at 20 cM of chromosome 12p13, which was prioritized based on the strongest support for linkage in our FAD datasets and the report of significant association between sporadic AD and variations nearby GAPDH [9] . From a public database (www.ncbi.nlm.nih.gov/SNP/), we identified 14 SNPs in the intragenic sequence of seven genes with minor allele frequencies >8%. This selection shown in Table 3 included five SNPs that were significant in an earlier study [9] . SNP genotyping was performed using the GenomeLab SNPstream System (Beckman Coulter Inc., Fullerton, CA, USA) [14] . Primer sequences were designed using software provided at www.autoprimer.com (Beckman Coulter Inc., Fullerton, CA, USA) and are available upon request. APOE genotyping was performed as previously described [15] . A subset of 100 samples was genotyped twice for every SNP with a concordance rate of 99%.
Statistical analyses
Linkage analysis We conducted two-point linkage analyses, considering both dominant and recessive modes of inheritance under an affecteds-only model [16, 17] . For all linkage analyses, we used microsatellite markers only, and assumed a susceptibility allele frequency of 0.001, and penetrance values of 0.001 for gene carriers and 0.0 for non-carriers. Although these affecteds-only parameters are artificial, they lead to statistical tests with properties that are comparable to 'model-free' analyses when studying common diseases [18] . The analysis was implemented using the MLINK program from the FASTLINK package [19, 20] .
We then performed a multipoint affected sibpair linkage analysis using GENEHUNTER (version 2.1) to increase the information content at a given chromosomal location. For this analysis, we combined the Hispanic and North European FAD datasets. To take into account differences in allele frequency between the ethnic groups, we treated one marker as two tightly linked markers (i.e., θ=0.0001 between members of each marker pair), and assigned one to each ethnic group. We then computed ethnic-specific allele frequencies for each marker. We used the weighted 'all pairs' option, and set the increment function to scan at 1.0 cM. The sibpair analysis calculated the probability of sharing zero, one, or two alleles (z 0 , z 1 , or z 2 ) identical by descent (IBD) between sib pairs, because susceptibility will have probabilities (z 0 , z 1 , and z 2 ) that differ from the expected Mendelian proportions [21, 22] . The LOD score was computed under the assumption of dominance, but restricting the parameters to Holmans's Triangle Inequality: 2z 0 ≤z 1 ≤1/2 and z 0 +z 1 +z 2 =1 [23, 24] .
Association analysis of the case-control data Prior to the allelic and genotypic association analyses, we assessed the SNP genotype data for deviation from Hardy-Weinberg equilibrium in the controls from the case-control dataset and in the founders from the FAD datasets using the PEDSTAT program [25] . For all association analyses, only the SNP markers were used. We compared the allelic and genotypic association in the case-control dataset using the conventional χ 2 test or Fisher's exact test when the expected frequency of one or more cells was fewer than five [26] . In addition, we adjusted for covariates APOE ɛ4, sex, and age-at-onset in patients, and age at the last examination in controls using a multivariate logistic regression analysis. For this analysis, we dichotomized the SNP genotype as either having at least one or no copy of the minor allele. Similarly, an APOE ɛ4 carrier was defined as an individual having one or more APOE ɛ4 alleles. The association was considered significant if the nominal p value was below 0.05 in two independent datasets. Haplotype associations were assessed using HAPLO. STATS which computes a haplotype-specific empirical p value for each haplotype and a permutation-based global p value for the haplotype set [27] .
Association analysis of the family data Association in the FAD datasets was evaluated using FBAT version 1.7.2 [28] . Because our previous studies showed significant linkage in this region [4, 5] , we computed the empirical variance function in the FBAT program to test the null hypothesis of no association in the presence of linkage. An additive genetic model was assumed throughout the study. Haplotype analyses using a sliding window approach in which overlapping sets of two to three contiguous SNPs were conducted in the Northern European case-control dataset and Caribbean Hispanic FAD dataset because a number of SNPs in these two datasets showed nominally significant association in the two-point analysis. We computed empirical p values for haplotype-specific p values, and permutation-based global p values to adjust for multiple testing for a specific haplotype set. To minimize the risk of false positive findings from haplotype analysis, we performed a multi-marker analysis using SNPs that were significant in haplotype analysis. This analysis allows a test of the null hypothesis without the required assumption of no recombination between the SNPs [29] . We then conducted an APOE ɛ4-positive conditional analysis because earlier linkage analyses of the Caribbean Hispanic families [5] and Caucasian families [30] revealed possible influence of APOE on this region. For this purpose, we considered an individual with AD and at least one APOE ɛ4 allele affected. An individual was considered unknown otherwise. Conversely, we conducted an APOE ɛ4-negative conditional linkage analysis, in which an individual with AD was considered affected in the absence of an APOE ɛ4 allele.
Analysis of combined family and case-control data We combined the Caribbean Hispanic families and Caucasian cases-controls which those two datasets had nominally significant associations for rs2532500 and rs740850. For this purpose, we performed the DFAM procedure of the PLINK package [31] . This approach combines family data with unrelated cases and controls. The family data were analyzed using the transmission disequilibrium test using sibships as in sibTDT [32] , and the case-control data were analyzed using a clustered-analysis of the Cochran-Mantel-Haesnzel test, which assesses allelic association conditional on cluster based on affection status. We examined the SNPs after combining all three datasets for the sake of completeness.
Assessment of linkage disequilibrium Linkage disequilibrium (LD) structure was examined with the program HAPLOVIEW version 3.32 [33] (Fig. 2) . Haplotype blocks were defined using a confidence interval algorithm [34] . The default settings were used in these analyses, which create 95% confidence bounds on D′ to define SNP pairs in strong LD. Haplotypes and their frequencies were estimated using an accelerated expectation-maximization (EM) algorithm similar to the partition/ligation method implemented in HAPLOVIEW [35] .
Results
Linkage analysis The analysis of the 23 microsatellite markers from the pericentromeric region of chromosome 12 generated a peak overall two-point LOD score of 3.46 at 19.7 cM in the North European FAD dataset ( Table 2 , Fig. 1 Fig. 1 ). Thus, the two datasets independently support linkage to the chromosome 12p13 region. In addition, the North European FAD dataset also gave weakly positive scores for three markers in a 4-Mb interval near 71 cM (LOD≤1.91, Table 2 ).
Association analysis For the 14 SNPs within the 6.4-6.6 Mb region (167 kb interval at 20 cM), we observed seven SNPs with nominal p < 0.05 in five different neighboring genes in at least one of the three datasets (Table 3) D12S374  D12S1623  D12S397  D12S1695  D12S77  D12S89  D12S391  D12S358  D12S269  D12S373  D12S1042  D12S1090  D12S1701  D12S390  D12S96  D12S398  D12S1632  D12S90  D12S83  D12S375  D12S1722  D12S92 
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North European Families
Caribbean Hispanic Families Fig. 1 The same set of 14 SNPs were examined in the two FAD datasets using a single-point, family-based association analysis [28] . None of the SNPs were associated with FAD in the North European families. However, in the Caribbean Hispanic FAD dataset, there were two significant SNPs, one in the NCAPD2 (SNP 7: rs740850, p=0.0097), the other in GAPDH (SNP 10: rs1060620, p=0.0418). Both associations remained significant in the APOE conditional analysis in APOE ɛ4-positives (rs740850, p=0.015; and rs1060620, p=0.049).
We then performed association analysis after combining the two datasets that had positive allelic association, namely Caribbean Hispanic families and Caucasian cases and controls (Table 4) . We found rs2532500 and rs740850 to be significantly associated with AD. For rs2532500, the T allele was significantly associated with AD after correcting for multiple testing (empirical p = 0.0259); while for rs740850, the A allele was significantly associated with AD (empirical p=0.0048). However, when all three datasets were used for sake of completeness, none of the SNPs were found to be significant. Only rs3741916 (empirical p= 0.0622), adjacent to rs740850 (empirical p =0.1115), approached experimentalwise significance.
Haplotype analysis was performed in the North European case-control and Caribbean Hispanic FAD datasets to follow-up the significant findings in the single-point analysis (Table 5 ). Haplotype analysis was not performed in the North European FAD dataset because none of the SNPs showed significant association in the single-point analysis. In the North European case-control dataset, the haplotypes containing the A allele at rs740850 (SNP 7) were positively associated with AD, whereas the haplotypes containing the G allele at rs740850 (SNP 7) were protective. Although haplotypes containing the C allele at rs2072374 (SNP 6) or the G allele at rs3741916 (SNP 8) were significantly associated with AD, the direction of the haplotype association (i.e., whether a haplotype was deleterious or protective against AD) was inconsistent. In the Caribbean Hispanic FAD dataset, a similar pattern of haplotype association was observed. Haplotypes including rs740850 (SNP 7) were significant. Specifically, haplotype C-A at SNP 6-7 and haplotype C-A-C at SNP 6-7-8 were positively associated with AD (Z=1.96-2.12, both haplotype-specific empirical p and global p<0.05). On the other hand, haplotypes T-C-G at SNP 5-6-7 (rs7311174, rs2072374, and rs740850) showed a consistent protective effect on AD in the two datasets (North European casecontrol set, haplotype-specific p value=0.032; global p value=0.080; Caribbean Hispanic set, haplotype-specific p value=0.005; global p value=0.0074). The T-C-G haplotype frequencies for the North European case-control dataset and Caribbean Hispanic dataset were comparable (0.359 and 0.408, respectively).
In the GAPDH gene, haplotypes that included the T allele at rs1060620 (SNP 10) were significantly associated with AD in both the North European case-control and Caribbean Hispanic family datasets. Haplotype C-A-T at For estimation of empirical p value, we estimated empirical p value based on 10,000 replicates. rs2532501  rs2532500  rs2008134  rs2072373  rs7311174  rs2072374  rs740850  rs3741916  rs3741918  rs1060620  rs1060619  rs740852  rs1639122  rs3741924   1  2  3  4  5  6  7  8  9  10 11 12 13 SNP 8-9-10 was significantly associated with AD in both datasets (haplotype-specific empirical p=0.046, 0.017, respectively), and haplotype T-A at SNP 10-11 (haplotype-specific empirical p value=0.03) was significantly associated with AD in the Caribbean Hispanic family dataset. Lastly, the multi-marker analysis of Caribbean Hispanic families supported the associations observed in the above haplotype analysis for SNPs 7-8 (p=0.030), SNPs 9-10 (p=0.048), and SNPs 6-7-8 (p=0.015).
Discussion
We conducted multi-stage fine mapping of the chromosome 12 locus between 12p13.2 and 12q24.2, spanning 70 cM, using two ethnically diverse FAD datasets and one casecontrol AD dataset. We examined these two datasets together because we hypothesized that there may present a common susceptibility gene(s) for LOAD in this region, since multiple datasets from more than one ethnic background yielded strong support for linkage and some of Fig. 2 The linkage disequilibrium (LD) pattern in the North European samples (a) and Caribbean Hispanic samples (b). LD was estimated across several single nucleotide polymorphisms in this chromosome region using the HAPLOVIEW software. The five-color scheme (white to red) represents the increasing strength of LD. Boxes with a D′ of 1 are shaded in bright red. Cells with D′<1 are shades of pink or red. Blue represents D′=1, but with a low confidence estimate for D′ those studies reported significant allelic association. The present linkage analyses of the NE Caucasian dataset as well as the Caribbean Hispanic FAD dataset continue to provide strong evidence for linkage at 15-20 cM on 12p. The subsequent association study of 14 SNPs spanning a 167-kb region under the linkage peak (Fig. 1) revealed nominally significant results for seven SNPs in a casecontrol study. However, only two of these SNPs located in two adjacent genes (NCAPD2 and GAPDH) demonstrated nominally significant association with AD in one of two FAD datasets (Table 3) . Those two SNPs (rs2532500 and rs740850) were significantly associated with AD, when we combined the Caribbean Hispanic family data with the NE Caucasian case-control data. Moreover, two haplotype sets spanning SNPs 6-10 were significant; particularly, haplotype C-A at SNPs 8-9 located in NCAPD2 were significantly associated with AD in both Caribbean Hispanic families and in North European case-control dataset.
Our findings localize to the same region that was identified by earlier reports, which detected a significant association between AD and six SNPs in or nearby GAPDH [9, 36] . Li and colleagues [9] observed somewhat different allelic associations with AD in three case-control series and one case-control series derived from a linkage study. This series-to-series heterogeneity of disease risk suggests that the observed AD associated SNPs are in fact in linkage disequilibrium with a disease-causing allele at a nearby site. All five SNPs that were significant in the study by Li and colleagues [9] were included in our study; however, only rs3741916 (SNP 8) generated a significant result. In our North European case-control dataset, we found the C allele of rs3741916 to be marginally associated with AD (p= 0.027). Further, in the Caribbean Hispanic FAD and NE Caucasian case-control datasets, the haplotypes that include the C allele at rs3741916 (e.g., haplotype C-A-T at SNPs 8-10) were associated with AD (Table 5 ). This finding is consistent with the results of a recent report by Lin and colleagues [36] , which conducted a study of North American FAD and an AD case-control datasets using eight SNPs in the PKP2P1, NCAPD2, and GAPDH genes. Of those, seven of these SNPs were included in the current investigation (Table 3 ). Lin and colleagues [36] found no associations in the family-based study. However, they did observe the CC genotype at rs3741916 (p=0.021) to be marginally associated with sporadic AD, and the G allele at rs3741916 be protective (p=0.014). In contrast, Li and colleagues [9] observed the G allele at rs3741916 to be over-represented in AD cases when compared with the frequency the G allele in controls.
It has been suggested that the rs3741916 polymorphism may affect the transcription of GAPDH since it is located at −8 bp of the start codon [9] . The contradictory findings across studies at rs3741916 may be due to allelic heterogeneity, and argues against the functional significance of this SNP. Another possible explanation for the inconsistencies in allelic association was suggested by Lin and colleagues [37] , in which effects from multiple loci and a varying degree of correlations among these variants can lead to changing direction of association in different samples. In our current datasets (Table 5) , however, two haplotype sets were consistently associated with AD: (1) haplotype C-A at SNPs 6-7 was over-represented in AD in Caribbean Hispanics; and (2) haplotypes containing C-A-T at SNPs 8-10 were over-represented in both datasets. Although our findings from two datasets are consistent to some extent, further examination is necessary to probe the region surrounding SNPs 6-10.
A recent report by De Ferrari and colleagues [38] proposed the low density lipoprotein receptor-related protein 6 (LRP6), located at ∼26 cM, as a susceptibility gene for late-onset AD, and hypothesized that LRP6 alters function of Wnt signaling components in AD. In our case-control dataset, we examined two SNPs identified by the authors (rs1012672 in exon 18 and rs2302685 in exon 14), but neither were significantly associated with AD (data not shown).
The current results support the hypothesis that the region surrounding NCAPD2 and GAPDH at chromosome 12p13 may harbor an AD susceptibility gene(s), and the two potential risk haplotypes are haplotype C-A at SNP 6-7 within NCAPD2 and haplotype C-A-T at SNPs 8-10 within GAPDH. However, the LD for the GAPDH region extends for approximately 130 kb (Fig. 2) , and has a dense genomic context, containing at least nine genes (Fig. 1) . Given significant results with several SNPs from the current study as well as that of two published reports [9, 36] , future studies need to investigate a more dense and broad SNP coverage of the interval on 12p detected by current linkage studies.
